Costs and cost-effectiveness of the Kerala pilot screening programme for diabetic retinopathy in the public health system

期刊论文
出版模式：

开放获取
发表日期：

2024年9月3日

查看全文

Raphael Wittenberg,
Robert Anderson,
Stuart Redding,
Bipin Gopal,
Rajeev Sadanandan,
Vasudeva Iyer Sahasranamam,
Simon George,
Lakshmi Premnazir,
Gopalakrishnan Netuveli,
Jyotsna Srinath,
Radha Ramakrishnan,
Dolores Conroy,
Sobha Sivaprasad

摘要

Background/objectives

The Government of Kerala initiated a pilot screening programme for diabetic retinopathy in 16 Family Health Centres in Thiruvananthapuram district in 2019 in collaboration with the ORNATE India project. The evaluation of this pilot included a study of its costs and cost-effectiveness to inform decisions about extending the programme throughout Kerala.

Subjects/methods

The participants comprise all 5307 people who were screened for diabetic retinopathy under the pilot programme for whom data could be collected.

Results

The costs of the pilot programme are estimated at INR 11.3 million (including INR 1.9 million costs to individuals) and the benefits at 514 QALYs, slightly over one QALY per person treated. The cost per QALY was INR 22,000, which is well below India’s Gross National Income per person.

Conclusions

Kerala’s 2019 pilot screening programme for diabetic retinopathy was highly cost-effective.